LISA GREENE: Open Payments
NPI 1346811411 · MONROE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,437 in 66 payments from 20 companies in 2025. Trend: 2023 $868 · 2024 $1,296 · 2025 $1,437
Food & beverage: $1,437
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $379 |
| ABBVIE INC. | 11 | $174 |
| GlaxoSmithKline, LLC. | 5 | $128 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $110 |
| PFIZER INC. | 4 | $95 |
| LKC Technologies, Inc. | 1 | $91 |
| Novo Nordisk Inc | 4 | $65 |
| Lilly USA, LLC | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
Products named: FARXIGA, VRAYLAR, TRELEGY ELLIPTA, CAPLYTA, JARDIANCE, AIRSUPRA, Ozempic, XIFAXAN.
Industry payments across NC — which companies pay providers there.
